A consequence of this signaling activity was the oncogenic role of SPCA2 in breast cancer cells, where dysregulation of expression led to constitutive Ca2+ influx, activation of MAP kinase pathways, high rates of proliferation and tumorigenesis. The gene discussed is ATP2C2; the disease is breast cancer.